Brian Joseph Lynch Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

MDGL Quotes by TradingView

Brian Joseph Lynch is SVP and General Counsel of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,691 shares of MDGL, which is worth approximately $5.96 Million. The most recent transaction as insider was on Jan 23, 2024, when has been sold 3,639 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K
0% 3M change
17.93% 12M change
Total Value Held $5.96 Million

Brian Joseph Lynch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
BUY
Grant, award, or other acquisition
-
3,639 Added 17.06%
17,691 Common Stock
Jan 16 2024
SELL
Payment of exercise price or tax liability
$231,480 $243.92 p/Share
949 Reduced 6.33%
14,052 Common Stock
Dec 05 2023
SELL
Open market or private sale
$227,330 $227.33 p/Share
1,000 Reduced 6.25%
15,001 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
$87,090 $87.09 p/Share
1,000 Added 5.88%
16,001 Common Stock
Dec 04 2023
SELL
Open market or private sale
$393,408 $218.56 p/Share
1,800 Reduced 10.71%
15,001 Common Stock
Dec 04 2023
BUY
Exercise of conversion of derivative security
$144,756 $80.42 p/Share
1,800 Added 9.68%
16,801 Common Stock
Nov 30 2023
SELL
Open market or private sale
$613,740 $204.58 p/Share
3,000 Reduced 16.67%
15,001 Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
$221,250 $73.75 p/Share
3,000 Added 14.29%
18,001 Common Stock
Nov 29 2023
SELL
Open market or private sale
$795,680 $198.92 p/Share
4,000 Reduced 21.05%
15,001 Common Stock
Nov 29 2023
BUY
Exercise of conversion of derivative security
$295,000 $73.75 p/Share
4,000 Added 17.39%
19,001 Common Stock
Jan 16 2023
BUY
Grant, award, or other acquisition
-
15,001 Added 50.0%
15,001 Common Stock
Jan 03 2023
SELL
Open market or private sale
$3,681,340 $283.18 p/Share
13,000 Reduced 100.0%
0 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$1,193,270 $91.79 p/Share
13,000 Added 50.0%
13,000 Common Stock
Dec 23 2022
SELL
Open market or private sale
$1,926,959 $275.28 p/Share
7,000 Reduced 100.0%
0 Common Stock
Dec 23 2022
BUY
Exercise of conversion of derivative security
$642,530 $91.79 p/Share
7,000 Added 50.0%
7,000 Common Stock
BJL

Brian Joseph Lynch

SVP and General Counsel
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MDGL